Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type

By Ulbrich H.   Fiebich B.   Dannhardt G.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 12, 2002-12 ,pp. : 953-959

Elsevier

Access to resources Recommend Favorite

Inhibition of 5-lipoxygenase and cyclooxygenase-2 pathways by pain-relieving plaster in macrophages

By Peng Shan-Ying   Liu Yang   Bao Xu-hong   Wang Lin   Zhang Fu-ying   Wang Feng   Wang Wen-jie  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 49, Iss. 7, 2011-07 ,pp. : 716-726

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Intervention of Cyclooxygenase-2 and 5-Lipoxygenase Pathways. Impact on Inflammation and Cancer

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3431-3447

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 3, 2007-02 ,pp. : 297-309

Bentham Science Publishers

Access to resources Recommend Favorite

A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase

By Rioja I.   Terencio M.C.   Ubeda A.   Molina P.   Tarraga A.   Gonzalez-Tejero A.   Alcaraz M.J.  

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite